How to Get Ozempic in the UK: NHS, Private Prescriptions, and What to Know

If you are searching for how to get Ozempic in the UK, you are probably already aware that this medication has become one of the most talked-about treatments for weight loss in recent years. But the reality of accessing it — legally, safely, and with proper medical oversight — is more nuanced than most online sources suggest.

This guide walks through the prescribing pathway in the UK, who is clinically eligible, what the NHS does and does not offer, and how to access treatment privately with appropriate medical supervision. Ozempic is a prescription-only medication, and any use for weight management must be subject to clinical suitability and ongoing monitoring.

What is Ozempic and how does it work?

Ozempic is a brand name for semaglutide, a medication that belongs to a class of drugs called GLP-1 receptor agonists. It was originally developed and licensed for the treatment of type 2 diabetes, where it helps to regulate blood sugar levels.

GLP-1 (glucagon-like peptide-1) is a hormone your body produces naturally after eating. It does several things: it signals the pancreas to release insulin, slows gastric emptying (meaning food stays in your stomach longer), and acts on appetite centres in the brain to reduce hunger. Semaglutide mimics this hormone, but in a more potent and longer-lasting form.

Ozempic is administered as a once-weekly subcutaneous injection, typically into the abdomen or thigh. The dose is gradually increased over several weeks to reduce the likelihood of gastrointestinal side effects.

Ozempic vs Wegovy — what is the difference?

This is a common source of confusion. Both Ozempic and Wegovy contain semaglutide and are manufactured by Novo Nordisk. The difference is in their licensed indication and dosing:

• Ozempic is licensed for type 2 diabetes. It is available in doses up to 2mg weekly.
• Wegovy is licensed specifically for weight management. It is available at a higher dose of 2.4mg weekly.

When clinicians prescribe semaglutide for weight loss, they may prescribe Wegovy (on-label for weight management) or, in some cases, Ozempic off-label. Off-label prescribing is a well-established practice in UK medicine — it means using a medication outside its specific marketing authorisation, which is lawful when a prescriber judges it clinically appropriate for an individual patient.

Throughout this article, when people search for “how to get Ozempic for weight loss,” they are often referring to semaglutide-based treatment more broadly. The prescribing decision — which formulation and dose — is made by your clinician based on your individual circumstances.

Is Ozempic available on the NHS for weight loss?

The short answer is: for most people, not easily.

NICE (the National Institute for Health and Care Excellence) published guidance in 2023 approving semaglutide 2.4mg (Wegovy) for weight management in adults with a BMI of 35 or above, or 30 and above with at least one weight-related comorbidity. However, this approval came with a significant caveat — it is only recommended as part of a specialist Tier 3 weight management service.

What are Tier 3 and Tier 4 weight management services?

The NHS structures weight management into tiers:

• Tier 1: Universal services — public health campaigns, general advice from your GP.
• Tier 2: Lifestyle interventions — community-based programmes such as group exercise or dietary counselling.
• Tier 3: Specialist multidisciplinary services — typically involving dietitians, psychologists, physicians, and sometimes pharmacotherapy. This is where NICE says semaglutide should be prescribed.
• Tier 4: Bariatric surgery.

The problem is access. Tier 3 services are not uniformly available across England, and where they do exist, waiting lists can stretch to 12 months or longer. Some areas of the country have no Tier 3 service at all. In Bristol and the surrounding region, referral pathways exist but capacity is limited.

Your GP can refer you to a Tier 3 service, but they cannot typically prescribe semaglutide for weight loss themselves within NHS commissioning arrangements. Some GPs may prescribe off-label in specific circumstances, but this is uncommon and depends on local guidelines and individual clinical judgement.

In practical terms, if you have a BMI over 30 and want to access GLP-1-based weight loss treatment in a reasonable timeframe, the private route is currently the more realistic option for most people.

Getting Ozempic privately in the UK

Private prescribing of semaglutide for weight management is legal and increasingly common in the UK. But there is a right way and a wrong way to do it.

The legitimate prescribing pathway

A responsible private prescribing pathway looks like this:

1. Initial consultation with a prescribing clinician — this should be a doctor (GMC-registered) or an independent prescriber who takes a full medical history, reviews your medications, and assesses your clinical suitability. This is not a tick-box exercise.
2. Clinical assessment — including your BMI, waist circumference, blood pressure, and relevant blood tests (typically HbA1c, thyroid function, liver function, renal function, and a lipid profile). These are necessary both to confirm eligibility and to establish a baseline for monitoring.
3. Discussion of risks and benefits — any clinician worth seeing will spend time explaining what semaglutide can and cannot do, the common side effects, and what the evidence actually shows. Individual results vary, and medication alone is rarely the complete answer.
4. Gradual dose titration — starting at a low dose (typically 0.25mg weekly) and increasing over 16 to 20 weeks. This reduces the incidence of nausea and other gastrointestinal effects.
5. Ongoing monitoring — regular follow-up appointments to assess response, manage side effects, repeat blood tests, and adjust the treatment plan. This is not a “prescribe and forget” medication.

At The Lagom Clinic in Redland, Bristol, this is exactly how we structure our weight loss programme. Dr Jack Ogden conducts each consultation personally — a full 30-minute appointment that covers medical history, examination, blood work, and an honest discussion about whether medication is the right approach for you. Not everyone who attends will be prescribed semaglutide, and that is as it should be.

What about online prescribers?

There are now numerous online services offering semaglutide prescriptions in the UK. Some of these are run by registered clinicians and provide a reasonable standard of care. Others are closer to a dispensing service with a thin veneer of clinical oversight.

The key questions to ask of any service, online or in person:

• Will I have a consultation with a named, GMC-registered prescriber?
• Will blood tests be required before prescribing?
• Is there a structured follow-up and monitoring programme?
• Can I contact the prescribing clinician if I have concerns?

If the answer to any of these is no, consider looking elsewhere. A prescription without proper assessment and follow-up is not safe prescribing — it is a transaction.

Who is eligible for semaglutide treatment?

Semaglutide for weight management is not appropriate for everyone. Eligibility is determined during a clinical assessment and typically requires:

• A BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, obstructive sleep apnoea, or cardiovascular disease).
• Previous attempts at weight management through dietary and lifestyle changes.
• A willingness to engage with lifestyle modification alongside medication — semaglutide works best as part of a broader programme, not as a standalone treatment.

Who should not take semaglutide?

There are clear contraindications. Semaglutide should not be prescribed to individuals who:

• Are pregnant or breastfeeding, or planning to become pregnant within the next two months (semaglutide should be stopped at least two months before conception).
• Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). GLP-1 receptor agonists have been associated with thyroid C-cell tumours in animal studies, although the relevance to humans is uncertain.
• Have a history of pancreatitis. While the causal relationship is debated, the precautionary principle applies.
• Have severe gastrointestinal disease, including gastroparesis.
• Have a history of eating disorders — this requires very careful consideration. Appetite-suppressing medication can interact with disordered eating in unpredictable ways, and a specialist assessment may be needed.

This is why a proper consultation matters. These are not questions that can be adequately assessed through a five-minute online questionnaire.

What to expect during a weight loss consultation

If you are considering medical weight loss and book a consultation at The Lagom Clinic, here is what the process typically involves.

Before the appointment

You will be asked to complete a medical questionnaire covering your health history, current medications, previous weight loss attempts, and your goals. This allows Dr Jack Ogden to review your background before you arrive, making the consultation itself more productive.

During the consultation

The appointment is 30 minutes with Dr Jack Ogden. It covers:

• Medical history review — including cardiovascular health, diabetes status, thyroid function, mental health, and any family history relevant to GLP-1 prescribing.
• Examination — weight, BMI, blood pressure, and waist circumference as a minimum.
• Blood tests — either taken during the appointment or arranged shortly after. These typically include HbA1c, fasting glucose, thyroid function, liver and kidney function, and a lipid profile.
• Discussion — this is the part that matters most. What are your goals? What have you tried before? What does your relationship with food look like? Is medication likely to help you, and if so, which approach is most appropriate?

Not everyone who attends a weight loss consultation will be prescribed medication. Some patients are better served by dietary and lifestyle support alone. Others may need investigation of an underlying condition (such as hypothyroidism or polycystic ovary syndrome) before weight management treatment begins. The consultation is a clinical assessment, not a prescription service.

After the consultation

If semaglutide or another prescription medication is clinically appropriate, you will receive a private prescription and guidance on self-injection technique. Follow-up appointments are built into the programme — typically at four weeks, then every eight to twelve weeks — to monitor progress, manage side effects, and adjust the plan as needed.

Our weight loss programme includes ongoing monitoring as standard, because prescribing without follow-up is not safe practice.

Consultations start from £125 for 30 minutes.

Alternatives to semaglutide

Semaglutide is not the only option. Depending on your clinical profile and preferences, your doctor may discuss the following alternatives.

Tirzepatide (Mounjaro)

Tirzepatide is a newer medication that acts on both GLP-1 and GIP receptors (a so-called “dual agonist”). It was originally licensed for type 2 diabetes under the brand name Mounjaro and has since received a UK licence for weight management (branded as Zepbound in some markets). Clinical trial data suggests tirzepatide may produce greater average weight reduction than semaglutide, although head-to-head real-world data is still emerging. Like semaglutide, it is a prescription-only medication administered by weekly injection and requires clinical assessment and ongoing monitoring.

Liraglutide (Saxenda)

Liraglutide is another GLP-1 receptor agonist, administered as a daily injection rather than weekly. It was the first GLP-1-based treatment licensed specifically for weight management in the UK. It is effective but generally produces more modest weight reduction than semaglutide, and the daily injection schedule is less convenient for many patients.

Orlistat

Orlistat works by a completely different mechanism — it blocks the absorption of approximately one-third of dietary fat in the gut. It is available on the NHS and can also be purchased over the counter at a lower dose (Alli). It is less effective than GLP-1-based treatments on average, and the gastrointestinal side effects (oily stools, flatulence, urgency) make it poorly tolerated by many patients. It remains an option for some individuals, particularly where injectable treatments are not suitable or preferred.

Lifestyle-only programmes

For some people, structured dietary and exercise support — without medication — is the right starting point. This might include working with a dietitian, an exercise physiologist, or addressing psychological factors such as emotional eating or binge eating. Medication and lifestyle approaches are not mutually exclusive; the strongest evidence supports combining both where medication is indicated.

Risks and side effects of semaglutide

Any honest discussion of semaglutide must include its risks. This medication is effective for many people, but it is not without side effects, and some of them are more than trivial.

Common side effects

The most frequently reported side effects are gastrointestinal and tend to be most pronounced during dose titration:

• Nausea — the most common side effect, affecting roughly 40% of patients in clinical trials. It is usually worst in the first few weeks and often improves with time and gradual dose increases.
• Diarrhoea and constipation — both are common. Dietary adjustments (smaller meals, adequate hydration, fibre intake) can help manage these.
• Abdominal pain and bloating — related to the delayed gastric emptying that is part of how the drug works.
• Injection site reactions — mild redness, swelling, or itching at the injection site. Usually minor and self-limiting.
• Headache and fatigue — reported in some patients, particularly early in treatment.

Less common but serious risks

• Pancreatitis — inflammation of the pancreas. Rare but potentially serious. Patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain.
• Gallbladder disease — rapid weight loss from any cause increases the risk of gallstones. Semaglutide-associated weight loss is no exception. Symptoms include right upper abdominal pain, particularly after fatty meals.
• Thyroid tumours — as mentioned above, GLP-1 receptor agonists have been associated with thyroid C-cell tumours in rodent studies. This has not been confirmed in humans, but as a precaution, semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma.
• Hypoglycaemia — uncommon when semaglutide is used for weight management in non-diabetic patients, but a risk if combined with other glucose-lowering medications.
• Acute kidney injury — rare, but can occur secondary to severe dehydration from vomiting or diarrhoea. Adequate fluid intake is important.

This is not an exhaustive list. Your prescribing clinician should discuss the full risk profile with you during your consultation, and you should receive the patient information leaflet with your medication.

Red flags: how to spot unsafe providers

The demand for GLP-1 weight loss medication in the UK has created a market that includes both reputable providers and those cutting corners. Here is what to watch out for.

Warning signs of an unsafe service

• No real consultation. If you can obtain a prescription by filling in a short online form with no video or face-to-face consultation, the clinical assessment is likely inadequate.
• No blood tests required. Prescribing semaglutide without baseline blood work is not safe practice. Blood tests are necessary to screen for contraindications and to establish a monitoring baseline.
• No follow-up or monitoring. A single prescription with no structured follow-up is a red flag. GLP-1 medications require ongoing clinical oversight.
• No named prescriber. You should know the name and GMC registration of the doctor prescribing your medication. If this information is not provided, ask for it.
• Unusually low prices. If the price seems too good to be true, the medication may be counterfeit, diverted from other markets, or prescribed without adequate clinical infrastructure behind it.
• Pressure to buy. A legitimate clinician will tell you if medication is not appropriate for you. If you feel pushed toward purchasing a prescription, that is not clinical care.

Counterfeit medication risk

The MHRA (Medicines and Healthcare products Regulatory Agency) has issued warnings about counterfeit semaglutide products circulating in the UK. These may contain incorrect doses, contaminated ingredients, or no active ingredient at all. Only obtain medication through a registered pharmacy, either with a private prescription from a named clinician or through an NHS pathway.

If you are unsure whether an online pharmacy is legitimate, check the MHRA register or look for the EU common logo (a green cross with a white stripe) on the pharmacy’s website, which links to the GPhC register.

Frequently asked questions

How much does Ozempic cost privately in the UK?

The cost of semaglutide varies depending on the dose and the provider. Medication costs typically range from £150 to £300 per month, separate from consultation fees. At The Lagom Clinic, initial weight loss consultations start from £125 for 30 minutes. We are transparent about costs and will discuss the full pricing of any recommended treatment during your appointment.

Can my GP prescribe Ozempic for weight loss?

In theory, yes — GPs have the authority to prescribe off-label. In practice, most NHS GPs are unable to prescribe semaglutide for weight loss due to local commissioning restrictions and cost pressures on NHS prescribing budgets. Your GP may refer you to an NHS Tier 3 weight management service, but waiting times are often lengthy. Private prescribing through a GMC-registered doctor is the most accessible route for most patients.

How quickly does semaglutide work for weight loss?

Most patients begin to notice reduced appetite within the first two to four weeks, even at the lowest starting dose. Clinically meaningful weight loss — typically defined as 5% or more of body weight — usually occurs within three to six months at therapeutic doses. Individual results vary considerably, and semaglutide is most effective when combined with dietary and lifestyle changes. It is not a quick fix; it is a tool that supports a longer-term process.

How long do I need to take semaglutide?

This is an important question without a simple answer. Clinical trials have shown that weight regain is common after stopping semaglutide, which suggests that for some patients, long-term use may be necessary to maintain results. For others, a defined course of treatment alongside permanent lifestyle changes may be sufficient. This is something to discuss with your prescribing clinician and review at regular follow-up appointments. Treatment duration should be based on your individual response and goals, not a one-size-fits-all protocol.

Is semaglutide safe long-term?

Semaglutide has been used for type 2 diabetes since 2017 and for weight management since 2021 (as Wegovy). The medium-term safety data is broadly reassuring, and the STEP and SELECT clinical trials have demonstrated cardiovascular benefits in certain patient populations. However, very long-term data (beyond five to ten years) for weight management use is still being gathered. As with any medication, the decision to use semaglutide involves weighing the known risks of continued obesity against the known and potential risks of the medication itself. This is a conversation best had with your doctor, not with a website.

Do I need to diet and exercise while taking semaglutide?

Yes. Semaglutide is not a replacement for healthy eating and physical activity — it is an adjunct. The clinical trials that demonstrated semaglutide’s effectiveness all included lifestyle intervention as part of the protocol. In practice, most patients find that the appetite reduction makes it easier to adopt healthier eating habits, and as weight decreases, physical activity often becomes more comfortable. But the medication works best when it is part of a broader commitment to sustainable change.

This article is for general information only and does not constitute medical advice. Ozempic, Wegovy, and Mounjaro are prescription-only medicines. Any treatment must be subject to clinical suitability, assessed during an individual consultation with a GMC-registered prescriber. Individual results vary. If you are considering weight loss medication, please book a consultation so we can assess whether treatment is appropriate for you.